Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$67.33 - $77.71 $3,568 - $4,118
53 New
53 $4,000
Q4 2023

Feb 05, 2024

BUY
$48.64 - $57.81 $2,140 - $2,543
44 New
44 $2,000
Q1 2022

May 06, 2022

SELL
$40.9 - $45.1 $13,783 - $15,198
-337 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$38.07 - $44.87 $12,829 - $15,121
337 New
337 $14,000
Q2 2021

Aug 10, 2021

SELL
$38.58 - $44.24 $2,700 - $3,096
-70 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$35.27 - $39.67 $2,468 - $2,776
70 New
70 $3,000
Q2 2020

Aug 10, 2020

SELL
$30.19 - $39.11 $6,762 - $8,760
-224 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$25.83 - $45.71 $1,420 - $2,514
55 Added 32.54%
224 $7,000
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $6,021 - $7,213
-159 Reduced 48.48%
169 $8,000
Q3 2019

Nov 13, 2019

BUY
$40.31 - $43.45 $13,221 - $14,251
328 New
328 $13,000
Q1 2019

May 13, 2019

SELL
$32.91 - $40.75 $26,327 - $32,600
-800 Closed
0 $0
Q4 2018

Jan 29, 2019

BUY
$31.73 - $39.04 $25,384 - $31,232
800 New
800 $28,000
Q2 2018

Jul 26, 2018

SELL
$26.84 - $34.32 $14,064 - $17,983
-524 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$26.26 - $29.17 $13,760 - $15,285
524
524 $15,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.